We’ve compiled the most relevant results based on your search. Please review the listings below to find what best meets your needs.
If you don’t see what you’re looking for, consider refining your search or adjusting the filters or using the form below to contact us.
DEA testing shows a sharp rise in the danger of counterfeit pills, with 60% now containing a potentially lethal dose of fentanyl—up from 40% in 2021. Often made by Mexican cartels to mimic real prescription opioids, these pills pose serious risks, reinforcing warnings against using non-prescribed medications.
This study examines the economic cost of opioid use disorder (OUD) and the societal value of preventing it. Using 2015–2018 data, it analyzes the financial burden across taxpayers, healthcare, and society, revealing increased spending despite a decline in OUD cases—largely due to the rising prevalence of fentanyl.
Investing in prevention programs targeting youth mental health and substance misuse yields strong financial and societal returns. Family-based and community interventions are cost-effective and reduce high-risk behaviors. Despite their success, scaling and funding remain challenges. The article urges increased prioritization of prevention amid rising adolescent fentanyl-related overdose deaths.